Department of Laboratory Medicine, Clinical Center, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892, USA.
J Mol Biol. 2012 Apr 20;418(1-2):65-81. doi: 10.1016/j.jmb.2012.02.005. Epub 2012 Feb 9.
APOBEC-3 proteins induce C-to-U hypermutations in the viral genome of various viruses and have broad antiviral activity. Generally, only a small proportion of viral genomes (<10(-)(2)) are hypermutated by APOBEC-3s, but often many cytidines (up to 40%) are converted into uridine. The mechanism of this unique selective hypermutation remains unknown. We found that rat APOBEC-1 overexpression had a hypermutation pattern similar to that of APOBEC-3s on its substrate apolipoprotein B (apoB) mRNA. Transient plasmid transfection of rat APOBEC-1 resulted in 0.4% and 1.8% hypermutations with apoB mRNA in HepG2 and McA7777 cells, respectively. The low frequency of hypermutated apoB mRNA targets was enriched by differential DNA denaturation PCR at 72-76 °C, with hypermutation levels increasing up to 67%. Up to 69.6% of cytidines in HepG2 and up to 75.5% of cytidines in McA7777 cells were converted into uridines in the hypermutated apoB mRNA. When rat APOBEC-1 was overexpressed by adenovirus, the hypermutation frequency of apoB mRNA increased from 0.4% to ∼20% and was readily detected by regular PCR. However, this higher expression efficiency only increased the frequency of hypermutation, not the number of affected cytidines in hypermutated targets. Rat APOBEC-1 hypermutation was modulated by cofactors and eliminated by an E181Q mutation, indicating the role of cofactors in hypermutation. The finding of an APOBEC-3 hypermutation pattern with rat APOBEC-1 suggests that cofactors could also be involved in APOBEC-3 hypermutation. Using hepatitis B virus hypermutation, we found that KSRP increased APOBEC-3C and APOBEC-3B hypermutation. These data show that, like rat APOBEC-1 hypermutation, cellular factors may play a regulatory role in APOBEC-3 hypermutation.
APOBEC-3 蛋白在多种病毒的基因组中诱导 C 到 U 的超突变,并具有广泛的抗病毒活性。通常,只有一小部分病毒基因组(<10(-)(2))被 APOBEC-3 超突变,但经常有多达 40%的胞嘧啶被转化为尿嘧啶。这种独特的选择性超突变的机制尚不清楚。我们发现,大鼠 APOBEC-1 的过表达在其apoB mRNA 底物上具有与 APOBEC-3s 相似的超突变模式。大鼠 APOBEC-1 的瞬时质粒转染导致 HepG2 和 McA7777 细胞中的 apoB mRNA 分别发生 0.4%和 1.8%的超突变。用 72-76°C 的差异 DNA 变性 PCR 富集低频率的超突变 apoB mRNA 靶标,超突变水平增加到 67%。高达 69.6%的 HepG2 细胞中的胞嘧啶和高达 75.5%的 McA7777 细胞中的胞嘧啶在超突变的 apoB mRNA 中被转化为尿嘧啶。当大鼠 APOBEC-1 通过腺病毒过表达时,apoB mRNA 的超突变频率从 0.4%增加到约 20%,并可通过常规 PCR 轻易检测到。然而,这种更高的表达效率只是增加了超突变的频率,而不是超突变靶标中受影响的胞嘧啶的数量。大鼠 APOBEC-1 的超突变受到辅助因子的调节,并通过 E181Q 突变消除,表明辅助因子在超突变中的作用。大鼠 APOBEC-1 的 APOBEC-3 超突变模式的发现表明,辅助因子也可能参与 APOBEC-3 超突变。利用乙型肝炎病毒超突变,我们发现 KSRP 增加了 APOBEC-3C 和 APOBEC-3B 的超突变。这些数据表明,与大鼠 APOBEC-1 超突变一样,细胞因子可能在 APOBEC-3 超突变中发挥调节作用。